Research
And Grants
To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.
The Institute of Cancer Research - $106,647
$106,647.00
October 2018
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.
Johns Hopkins Children's Center - $50,000
$50,000.00
July 2018
Using Zebrafish to Accelerate DIPG Drug Development.
Funding of Pediatric Brain Tumor Consortium Foundation - $16,800
$16,800.00
January 2018
The Campbell Family Institute for Cancer Research - $100,000
$100,000.00
October 2017
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets
Institute of Cancer Research - $102,432
$102,432.00
October 2017
Combinational strategies alongside ACVR1 inhibition in DIPG
The Regents of the University of California - $70,000
$70,000.00
October 2017
An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy
The Hospital for Sick Children - $100,560
$100,560.00
October 2017
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)
Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
$200,000.00
October 2017
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.